Discover how much money can be saved in your clinical trial!

Blog

Verified Video

Verified Clinical Trials Offers Virtual Clinical Trial Solution To Prevent Co-Enrollment or Duplicate Subjects

Conducting virtual or remote clinical trials? Verify your research subjects eligibility and ensure they are not concurrently enrolling in multiple clinical trials at once. Avoid co-enrollment in clinical trials or duplicate subjects in clinical trials as well as protocol violations. Select better quality subjects for your trial so that you can meet her in points

Read More »
Sees Progress in the Understanding

Verified Clinical Trials Sees Progress In The Understanding and Acceptance of Duplicate Subjects In Clinical Trials

We have seen tremendous progress within the clinical trials research industry in understanding the scope of the issue with duplicate subjects in clinical trials  or professional research subjects over the past few years.  Verified Clinical Trials (VCT) provides an easy to implement cost-savings approach to prevent duplicate subjects and other important protocol violations in your

Read More »
Screen Shot 2019 07 26 at 9.37.51 AM

Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany

Verified Clinical Trials (VCT) is excited to be conducting the First Annual European VCT Congress on 28th November in Munich, Germany. The meeting will include many of our current and future users of the VCT research subject database registry to prevent duplicate subjects in clinical trials and  as well as other protocol violations. The workshop

Read More »
Screen Shot 2018 08 11 at 12.17.32 PM

Subject Registries Reduce Duplicate Subjects Entering CNS Studies

Verified Clinical Trials (VCT) is the global research subject database registry utilized across all phases of clinical trials research to prevent duplicate subjects and other key protocol violations. Data shows that a research subject registry will detect and prevent duplicate subjects and other protocol violations.  Up to 10% in CNS clinical trials and much higher

Read More »